WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of denied petitions for this year, organized in reverse chronological order by date of certiorari petition.
Spansion, Inc., et al. v. ITC, et al., No. 11-127
Questions Presented:
Cert petition filed 7/27/11. Petition denied 11/28/11. |
Qualcomm Inc. v. ITC, No. 11-128
Questions Presented:
Cert petition filed 7/27/11. Petition denied 11/28/11. |
Barr Laboratories, Inc., et al. v. Cancer Research Technology Ltd., et al., No. 11-131
Questions Presented:
Cert petition filed 7/28/11. Conference 10/28/11. Petition denied 10/31/11. |
APP Pharmaceuticals, LLC v. Navinta LLC, No. 10-1502
Question Presented: Did the Federal Circuit err in creating a new body of federal common law to govern contracts assigning patents, in the absence of a significant conflict between state law and any federal interest that might justify preemption? Cert. petition filed 6/13/11. Conference 9/26/11. Petition denied 10/3/11. |
White v. Hitachi, Ltd., et al., No. 10-1504
Questions Presented:
Cert. petition filed 6/15/11. Distributed for conference of 9/26/11 on 7/27/11; Petition denied 10/3/11. |
Shum v. Intel Corp., No. 10-1444
Questions Presented:
Cert. petition filed 5/25/11. Conference 6/16/11; response requested 6/8/11; brief in opposition filed 8/8/11; distributed for conference of 9/26/11 on 8/24/11; Petition denied 10/3/11. WilmerHale represents respondent Intel Corp. |
Lockwood, et al. v. Sheppard, Mullin, Richter & Hampton, LLP, et al., No. 10-1339
Question Presented: Whether under the implied preemption principles in Buckman Co. v. Plaintiffs' Legal Comm., 531 U.S. 341 (2001), federal patent law bars an aggrieved patent owner-plaintiff from asserting a state law claim seeking relief for harm to patent property rights caused by a private party maliciously initiating a sham administrative patent reexamination proceedings before the U.S. Patent and Trademark Office, where "fraud on the agency" is not an element of the claim, and where the agency itself cannot remedy the harm addressed by state law. Cert. petition filed 4/28/11. Conference 9/26/11; Petition denied 10/3/11. iRunway Amicus Brief ISO Cert., Law Professors Amicus Brief ISO Cert., TPL Group and T. Tafas Amicus Brief ISO Cert. |
Max Rack, Inc. v. Hoist Fitness Sys., Inc., No. 10-1384
Question Presented: Whether it is a denial of due process in violation of the Fifth Amendment to the United States Constitution for the Federal Circuit Court of Appeals to merely affirm a decision of the District Court on the scope of a patent property right with no expressed independent analysis of issues for which de novo review is required. Cert. petition filed 5/11/11. Conference 9/26/11; Petition dismissed 8/9/11. |
Abbyy Production, LLC v. Nuance Communications, Inc., No. 10-1019
Questions Presented:
Cert. petition filed 2/10/11. Conference 4/15/11; response requested 4/7/11; conference 6/23/11; conference 6/27/11. Petition denied 6/28/11. |
L-3 Commc'ns Corp, et al. v. Honeywell Int'l Inc., et al., No. 10-491
Questions Presented:
Cert. petition filed 10/8/10. Conference 6/16/11. Petition denied 6/20/11. |
Applera Corp. v. Enzo Biochem, Inc., No. 10-426
Question Presented: Whether the Federal Circuit's standard for definiteness is consistent with the language of 35 U.S.C. § 112. Cert. petition filed on 9/23/10. Conference 12/10/10; CVSG 12/13/10; conference 6/16/11. Petition denied 6/20/11. |
Extreme Networks, Inc. v. Enterasys Networks, Inc., No. 10-1199
Questions Presented:
Cert. petition filed 3/31/11. Conference 6/2/11. Petition denied 6/6/11. |
Howmedica Osteonics Corp. v. Zimmer, Inc., et al, No. 10-1161
Questions Presented:
Cert. petition filed 3/14/11. Conference 5/12/11. Petition denied 5/16/11. |
MedioStream, Inc. v. Acer America Corp., No. 10-1090
Question Presented: Did the Federal Circuit err in reweighing a district court's discretionary § 1404(a) analysis in the manner of the 6th, 7th, 10th and 11th Circuits, or is the proper approach under the All Writs Act, 28 U.S.C. § 1651, that of the 1st and 3rd Circuits which decline review of discretionary venue decisions? Cert. petition filed 3/3/11. Conference 5/12/11. Petition denied 5/16/11. |
Eli Lilly & Co. v. Sun Pharm. Indus., Ltd, No. 10-972
Question Presented: Whether the Federal Circuit improperly transformed the doctrine of "double patenting," in conflict with a "vast body of precedent" cited by four dissenting judges, by creating a new bright-line rule that invalidates a subsequent patent on a nonobvious, newly discovered use of a basic invention solely because it was disclosed, but not claimed, in the final text of the earlier basic patent. Cert. petition filed 1/28/11. Conference 5/12/11. Petition denied 5/16/11. WilmerHale filed an amicus brief in support of cert on behalf of Pharmaceutical Research and Manufacturers of America. |
Princo Corp. v. Int'l Trade Comm. et al., No. 10-898
Question Presented: Should the equitable doctrine of patent misuse remain a flexible doctrine to be applied when a patent holder has impermissibly attempted to extend the scope of his patent, or, as a divided Federal Circuit has held, be conditioned on a showing of "leveraging," "with anticompetitive effects" and in a manner previously "held to be outside...the patent grant"? Cert. petition 1/5/11. Conference 5/12/11. Petition denied 5/16/11. WilmerHale represents respondent U.S. Philips. |
Mylan, Inc. v. Daiichi Sankyo Co., Ltd, No. 10-770
Question Presented: Whether, contrary to this Court's decision in KSR International Co. v. Teleflex Inc., 550 U.S. 398 (2007), the Federal Circuit has erred in applying a “lead compound test” as the exclusive standard for determining whether a patent claim directed to a new chemical compound is “obvious” and therefore invalid under 35 U.S.C. § 103(a). Cert. petition filed 12/8/10. Conference 3/18/11. Petition denied 3/21/11. |
Baran v. Medical Device Tech., Inc., No. 10-862
Question Presented: Whether 35 U.S.C. § 112, ¶ 6 permits a patent claim expressed as a "means...for performing a specific function" to be construed to require functions not recited int eh means clause. Cert. petition filed 12/29/10. 2010 Conference 3/4/11. Petition denied 3/7/11. |
Louisiana Wholesale Drug Co., Inc., et al. v. Bayer AG, et al., No. 10-762
Question Presented: Absent patent fraud or sham litigation, is a brand drug maker's substantial payment to a competing generic drug maker to forego judicial testing of the patent and restrict entry per se lawful under the Sherman Act? Cert. petition filed 12/6/10. Conference of 3/4/11. Petition denied 3/7/11. |
Wyers, et al. v. Master Lock Co., No. 10-899
Questions Presented:
Cert. petition filed 1/10/11. Waiver filed 1/26/11; conference 2/18/11. Petition denied 2/22/11. |
Papyrus Tech. Corp. v. New York Stock Exchange, Inc., No. 10-866
Question Presented: By failing to give the patent holder (1) notice that a newly identified technology might be used to invalidate a patent and (2) an opportunity to present evidence and set forth facts supporting the validity of the patent in view of this newly identified technology, did the trial court disregard Rule 56 and deprive the patent holder of a property right without due process of law? Cert. petition filed 12/30/10. Waiver filed 1/13/11; conference 2/18/11. Petition denied 2/22/11. |
Landmark Screens, LLC v. Morgan, Lewis & Bockius LLP, et al., No. 10-499
Question Presented: Whether a legal malpractice claim against a patent lawyer that involves no actual patent and will have no impact on patent rights arises under an Act of Congress relating to patents so as to invoke the exclusive jurisdiction of the federal district courts under 28 U.S.C. § 1338. Cert. petition filed 10/12/10. Response requested 11/16/10, conference 2/18/11. Petition denied 2/22/11. Court of Appeals of California, Sixth Appellate District Opinion |
Romala Stone, Inc. v. The Home Depot USA, Inc., No. 10-777
Questions Presented:
Cert. petition filed 12/8/10. Waiver filed 12/23/10; conference 1/21/11. Petition denied 1/24/11. |
Vanderbilt University v. ICOS Corporation., No. 10-412
Questions Presented:
Cert. petition filed 9/21/10. Response requested 10/20/10; conference 1/21/11. Petition denied 1/24/11. |
Apotex, Inc. v. Sebelius, No. 10-453
Question Presented: May a generic drug manufacturer forfeit marketing exclusivity under 21 U.S.C. § 355(j)(5)(D) based on “unilateral” action by the holder of the challenged patent? Cert. petition filed 10/4/10. Conference 1/14/11. Petition denied 1/18/11. |
Desenberg v. Google, Inc., No. 10-706
Questions Presented:
Cert. petition filed 11/26/10. Waiver filed 12/6/10. Petition denied 1/10/11. |
Avid Identification Sys., Inc. v. The Crystal Import Corp., et al., No. 10-509
Questions Presented:
Cert petition filed 10/13/10. Conference 1/7/11. Petition denied 1/10/11. |
Patent certiorari petitions denied this year
Patent certiorari petitions denied in: 2015, 2014, 2013, 2012, 2011, 2010, 2009
For more information on this or other patent appeal matters, contact:
Joseph J. Mueller +1 617 526 6396 [email protected]
Thomas G. Saunders +1 202 663 6536 [email protected]
Leslie Pearlson +1 617 526 6809 [email protected]